World Bank funding for COVID-19 vaccine deployment exceeds $ 4 billion for 50 countries
The World Bank announced today that it will provide more than $ 4 billion for the purchase and deployment of COVID-19 vaccines for 51 developing countries, half of which in Africa. More than half of the funding comes from the International Development Association (IDA), the Bank’s fund for the world’s poorest countries, and is subject to grants or very concessional terms. This financing is part of the Bank’s commitment to help low- and middle-income countries acquire and distribute vaccines and strengthen their health systems.
The World Bank has reiterated its call on governments, pharmaceutical companies and organizations involved in the procurement and delivery of vaccines to help increase transparency and create greater public information regarding contracts, options and agreements of vaccines; vaccine financing and delivery agreements; and doses delivered and future delivery plans. He called on countries that anticipate excess vaccine supplies in the coming months to distribute their excess doses and options as soon as possible, in a transparent manner, to developing countries with adequate distribution plans.
Since the beginning of the COVID-19, the World Bank Group approved more than 150 billion dollars to combat the health, economic and social impacts of the pandemic. Since April 2020, the Bank has increased its funding by more than 50%, helping more than 100 countries meet emergency health needs, strengthen pandemic preparedness, while helping countries protect the poor and jobs , and launch a climate-friendly recovery. .
“The World Bank is helping developing countries in all regions of the world to purchase and deploy vaccines â, mentionned Axel van Trotsenburg,â¯Managing Director of World Bank Operations. âSignificant challenges remain regarding vaccine deployment and reluctance. We are taking action on all fronts to address these challenges, working in solidarity with international and regional partners to accelerate doses to as many people as possible and to improve disease surveillance, preparedness and response. “
All the details of the World Bank’s immunization operations are published on our vaccination operations portal, with regular updates. The $ 4 billion supports COVID-19 vaccination efforts in Afghanistan, Bangladesh, Benin, Cabo Verde, Cambodia, Comoros, Republic of Congo, Ivory Coast, Democratic Republic of Congo, Ecuador, El Salvador, Eswatini, Ethiopia, Gambia, Georgia, Ghana, Guinea, Guinea Bissau, Guyana, Honduras, Indonesia, Jordan, Kenya, Kosovo, Kyrgyz Republic, Laos RDP, Lebanon, Lesotho, Madagascar, Malawi, Moldova, Mongolia, Mozambique, Nepal, Niger, Pakistan, Papua New Guinea, Philippines, Rwanda, SÃ£o TomÃ© e PrÃncipe, Senegal, Sierra Leone, South Sudan, Sri Lanka, Sudan, Tajikistan, Togo, Tunisia, Ukraine, Yemen and Zambia.
The Bank’s vaccine financing program is designed to be flexible. It can be used by countries to acquire doses by COVAX, the working team on vaccine procurement in AfricaAVATT) or other sources. It also finances the deployment of vaccines and the strengthening of health systems, such as cold chains for vaccines, training of health workers, data and information systems, and communication and awareness campaigns among key stakeholders who are essential to ensure uptake of vaccination. The Bank has aligned its eligibility criteria for COVID-19 vaccines with revised eligibility criteria COVAX and other multilateral partners.
The World Bank is partnership with the African Union and the African Center for Disease Control, supported by the World Bank, to support AVATT initiative with resources to enable countries to purchase and deploy vaccines for up to 400 million people across Africa. The Bank also convenes a working group with the IMF, WHO, WTO, and other partners to monitor, coordinate and advance the delivery of COVID-19 vaccines to developing countries.
The Bank continues to work with governments and partners (Unicef, the Global Fund, WHO, and GAVI) to assess the readiness of more than 140 developing countries to deploy vaccines. Countries have made good progress since the publication of the first report. The latest results show that 95 percent of countries have developed national immunization plans, 79 percent have safety measures in place, and 82 percent have population priorities to receive the vaccine. However, only 59 percent have plans to train the large number of vaccinators needed and less than half have a plan in place to generate public trust, confidence and demand for COVID-19 vaccines.
Distributed by APO Group on behalf of the World Bank Group.
Africanews provides APO Group content as a service to its readers, but does not edit the articles it publishes.